Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Murdoch Childrens Research Institute
With
University of Tasmania
University College Hospital, Ibadan
Sacred Heart Hospital Lantoro
University of Ibadan
Trial description: A randomised cross-over trial of manual versus automated control of oxygen (OxyMate) for preterm infants on bCPAP. This trial will use an established technology (automated oxygen titration algorithm, VDL1.1) partnered with a low-cost bCPAP device in a low-resource setting. It will involve preterm infants requiring bCPAP respiratory support with allocation to OxyMate or manual oxygen control for consecutive 24 h periods in random sequence.
Objectives: This trial seeks to examine safety and potential efficacy of our automated oxygen configuration (OxyMate) in preterm infants in a setting characterised by financial constraints, workforce limitations, and underdeveloped infrastructure, and assess contextual feasibility and appropriateness to inform future definitive clinical trials and product development.
Age
0–0
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
\<34 weeks gestation (or birth weight \< 2kg if gestation not known)
≥12 hours old
Receiving CPAP support and supplemental oxygen (FiO2 \>0.21) for respiratory insufficiency
Projected requirement for CPAP and oxygen therapy for \> 48 hours
You may not be if
Deemed likely to fail CPAP in the next 48 hours
Deemed clinically unstable or recommended for palliation by treating team
Cause of hypoxaemia likely to be non-respiratory - e.g. cyanotic heart disease
Informed consent from parent/guardians not obtained